Imugene presents new proof of concept data on stomach cancer

Imugene Ltd (ASX:IMU, OTC:IUGNF) has presented new and significant data on HER-Vaxx at the World Congress of Gastrointestinal Cancer in Barcelona. Targeting...

Related Keywords

Barcelona , Comunidad Autonoma De Cataluna , Spain , Austria , Vienna , Wien , Joshua Tobias , Imugene Limited , Translational Research , World Congress On Gastrointestinal Cancer , World Congress , Imugene Ltd , University Of Vienna , Gastrointestinal Cancer , Gastric Cancer , Medical University ,